Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2025	Dec. 31, 2024
Cash flows from operating activities
Net loss	$ (39,678)	$ (12,536)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	521	452
Stock-based compensation	9,348	8,633
Provision for credit losses	129	(193)
Common stock warrant liability adjustment	26,571	(9,293)
Impairment of intangible and other assets	46	1,904
Amortization of right of use assets	69	929
Amortization of debt financing costs	2,155	1,095
Accrued warrant exchange transaction costs	41	0
(Gain)/loss on extinguishment of debt	0	418
(Gain)/loss on forgiveness on interest accrued	0	(508)
Write-off of prepaid deposit	347	0
Other adjustments, net	367	414
Changes in assets and liabilities:
Accounts receivable	(10,971)	2,030
Prepaid expenses and other assets	(1,048)	(30)
Inventory	(4,927)	(4,139)
Accounts payable and accrued and other expenses	5,426	1,322
Lease liabilities	(100)	(1,178)
Other liabilities	0	(769)
Deferred revenue	912	240
Net cash used in operating activities	(10,792)	(11,209)
Cash flows from investing activities
Purchase of property and equipment	(273)	(35)
Purchase of intangible assets	(114)	(87)
Capitalized internal-use software development costs	(556)	(639)
Net cash used in investing activities	(943)	(761)
Cash flows from financing activities
Proceeds from issuance of preferred stock and warrants	0	9,250
Proceeds from issuance of common stock	32,109	10,590
Proceeds from short-term borrowings	75,181	48,198
Payments of short-term borrowings	(74,638)	(51,514)
Proceeds from long-term borrowings	0	7,500
Payments of long-term borrowings	(488)	(5,000)
Payments related to debt extinguishment costs	0	(761)
Employee taxes paid related to the net share settlement of stock-based awards	(1,623)	(1,031)
Proceeds related to the issuance of common stock under stock plans	1,670	811
Debt financing costs paid	(174)	(930)
Warrant exchange transaction costs paid	(1,391)	0
Proceeds from exercise of common stock warrants	1,822	0
Other, net	562	363
Net cash provided by financing activities	32,115	16,044
Net change in cash, cash equivalents, and restricted cash	20,380	4,074
Cash, cash equivalents, and restricted cash at beginning of period	20,631	16,557
Cash, cash equivalents, and restricted cash at end of period	41,011	20,631
Supplemental disclosure of cash flow information:
Cash paid for income taxes	45	30
Cash paid for interest	1,590	4,051
Issuance of common stock in connection with warrant exchange	46,884	0
Purchases of property and equipment included in accounts payable	34	0
Purchases of intangible assets included in accounts payable	102	0
Conversion of preferred stock	0	6,469
Accretion on preferred stock and redeemable common stock	3,476	4,951
Issuance of common stock warrants to underwriter	0	(382)
Equity issuance costs included in accounts payable and accrued liabilities	0	286
Stock-based compensation for software development	97	86
Preferred Stock and Warrants
Cash flows from financing activities
Issuance costs paid	0	(395)
Common Stock
Cash flows from financing activities
Issuance costs paid	(639)	(587)
Issuance costs paid related to prior year common stock, preferred stock, and warrants	$ (276)	$ (450)